Oncology Center of Excellence

Arming you in the fight against cancer.

With more than 17 million new cases of cancer and almost 10 million cancer deaths reported worldwide last year, there remains a huge unmet medical need for more effective and better tolerated therapies for cancer patients.1 

We work with more urgency than ever in today’s complex development environment. Helping clients achieve the best chance of success in delivering new medical breakthroughs to the patients that need them is Parexel’s mission.  This is why we created our Parexel Oncology Center of Excellence (CoE).  

Accelerated access to the best minds to guide your clinical development program

Our Oncology CoE combines our new early advisory core service of medical, regulatory, genomics/biomarkers, and biostatistics experts with an experienced multi-disciplinary team and key technology platform partnerships to bring your breakthrough treatments to market faster, because we know patients are waiting for them.

By engaging our Oncology CoE, your team can benefit from simplified access to our extensive experience in oncology drug development, resulting in:

  • Improved study design and operational plans, increasing the likelihood of success
  • Acceleration of study start-up timelines achieved through earlier engagement, programmatic asset management and standardization
  • Greater predictability and reduced changes in scope
  • Improved interactions with regulatory agencies, leading to a higher success rate with regulatory submissions
     
If you want to lead the way in patient-centric oncology trials, you need to work with people who care

We put all we’ve got into clinical development of cancer therapies because we care about the patients who are waiting for these more effective and better tolerated therapies. We have invested in our oncology expertise by hiring some of the best minds and implementing the latest innovations to give your novel therapy a better chance at success.

Our oncology expertise includes:

  • Recent key medical oncologist/hematologist and ex-FDA appointments
  • 50+ physicians with oncology expertise
  • Expertise in Asia-Pac, including China and Japan
  • Expertise in innovative study designs:
    • Adaptive trials
    • Precision medicine trial
    • Real-world evidence trials
    • Patient-centric trials
  • Clinical Pharmacologists and Quantitative Clinical Development (QCD) Scientists
  • Virtual Trials – hybrid and fully virtual
  • Medical imaging expertise
  • Integrated medical writing team
  • 1,000+ project staff with oncology expertise 

 

​​​​​​​Over the last 5 years, Parexel’s oncology experience has included:

 

Oncology coe stats 2.jpg​​​​​​​

Partnering to help deliver new therapies to patients sooner

Parexel is committed to helping clients bring cutting edge therapies to treat and potentially cure patients with cancer. Technological innovations, such as artificial intelligence (AI) and machine learning, play a key part by driving efficiencies in study design, site selection, patient recruitment, medical imaging and more. We work with best-in-class, innovative partners to help clients deliver novel treatments to patients faster.  A few examples include:

 
We want to help you help patients

Through our Oncology CoE, you can rapidly and easily engage our subject matter experts across multiple functions to optimize and simplify your program development and design.  Contact us today to start a discussion on how we can help you maximize your opportunity for clinical development success. Reach us at OncologyCoE@parexel.com.

1. Source: https://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer

We are always available for a conversation.

*